Designing a novel multi‐epitope antigen for diagnosing human cytomegalovirus infection: An immunoinformatics approach
Biotechnology and Applied Biochemistry · 2025
DOI: 10.1002/bab.2677 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2025. Verfasst von Marzieh Asadi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Shiraz, Ira…. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Cytomegalovirus, Antigens, Viral, Computational Biology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Human cytomegalovirus (HCMV) infection can lead to congenital infections and severe complications, particularly in immunocompromised individuals. Current serological tests for diagnosing HCMV infection often face limitations in sensitivity and specificity. Developing multi‐epitope antigens for serological assays offers the potential for enhancing diagnostic accuracy. This study aimed to design a novel multi‐epitope antigen for HCMV infection diagnosis using immunoinformatic approaches. Five tegument proteins (universal protein resource [UniProt] ID: Po8318, Po6725, F5HC97, Q6RX10, and F5HC05) were selected based on their antigenic properties and literature review. Six linear B‐cell epitopes were predicted within conserved regions of each antigen sequence and linked with appropriate linkers. The designed multi‐epitope antigen underwent thorough evaluation for physicochemical properties, solubility, antigenicity, and cross‐reactivity. Additionally, the three‐dimensional structure of the antigen was predicted, refined, and validated. The nucleotide sequence of the designed antigen was optimized for successful expression in Escherichia coli and inserted into a pET23a (+) vector. Immunoinformatic analysis revealed that the multi‐epitope antigen exhibits stability, antigenicity, and lacks cross‐reactivity. Our findings suggest that this multi‐epitope antigen is a promising candidate for diagnosing HCMV infection. However, further validation through laboratory testing is required to confirm its diagnostic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Shiraz, Iran.
- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Science, Shiraz, Iran.
- Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Science, Shiraz, Iran.
- Recombinant Protein Laboratory, Department of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Marzieh Asadi, Navid Nezafat, Zohreh Mostafavi-Pour, Amir Savardashtaki
Zitieren
APA
Asadi, M., Ghasemi, Y., Nezafat, N., Sarkari, B., Baneshi, M., Mostafavi-Pour, Z., Anbardar, M. H., & Savardashtaki, A. (2025). Designing a novel multi‐epitope antigen for diagnosing human cytomegalovirus infection: An immunoinformatics approach. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2677
Vancouver
Asadi M, Ghasemi Y, Nezafat N, Sarkari B, Baneshi M, Mostafavi-Pour Z, et al. Designing a novel multi‐epitope antigen for diagnosing human cytomegalovirus infection: An immunoinformatics approach. Biotechnology and Applied Biochemistry. 2025. doi:10.1002/bab.2677
BibTeX
@article{Asadi2025,
author = {Asadi, Marzieh and Ghasemi, Younes and Nezafat, Navid and Sarkari, Bahador and Baneshi, Maryam and Mostafavi-Pour, Zohreh and Anbardar, Mohammad Hossein and Savardashtaki, Amir},
title = {Designing a novel multi‐epitope antigen for diagnosing human cytomegalovirus infection: An immunoinformatics approach},
journal = {Biotechnology and Applied Biochemistry},
year = {2025},
doi = {10.1002/bab.2677}
}
EUVIMED